These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 18206959)
1. Role of extracellular signal-regulated kinases (ERK) in leptin-induced hypertension. Wójcicka G; Jamroz-Wiśniewska A; Widomska S; Ksiazek M; Bełtowski J Life Sci; 2008 Feb; 82(7-8):402-12. PubMed ID: 18206959 [TBL] [Abstract][Full Text] [Related]
2. Time-dependent transition from H(2)O(2)-extracellular signal-regulated kinase- to O(2)-nitric oxide-dependent mechanisms in the stimulatory effect of leptin on renal Na+/K+/-ATPase in the rat. Marciniak A; Borkowska E; Kedra A; Rychlik M; Beltowski J Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1216-24. PubMed ID: 17184504 [TBL] [Abstract][Full Text] [Related]
3. Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertension. Bełtowski J; Jamroz-Wiśniewska A; Wójcicka G; Lowicka E; Wojtak A Mol Cell Biochem; 2008 Dec; 319(1-2):163-74. PubMed ID: 18690414 [TBL] [Abstract][Full Text] [Related]
4. Transactivation of epidermal growth factor receptor in vascular and renal systems in rats with experimental hyperleptinemia: role in leptin-induced hypertension. Jamroz-Wiśniewska A; Wójcicka G; Łowicka E; Ksiazek M; Bełtowski J Biochem Pharmacol; 2008 Apr; 75(8):1623-38. PubMed ID: 18282556 [TBL] [Abstract][Full Text] [Related]
5. Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia. Beltowski J; Wójcicka G; Jamroz-Wiśniewska A; Borkowska E; Marciniak A Life Sci; 2005 Aug; 77(15):1855-68. PubMed ID: 15913657 [TBL] [Abstract][Full Text] [Related]
8. Regulation of renal ouabain-resistant Na+-ATPase by leptin, nitric oxide, reactive oxygen species, and cyclic nucleotides: implications for obesity-associated hypertension. Bełtowski J; Borkowska E; Wójcicka G; Marciniak A Clin Exp Hypertens; 2007 Apr; 29(3):189-207. PubMed ID: 17497345 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Beltowski J; Wójcicka G; Marciniak A; Jamroz A Life Sci; 2004 Apr; 74(24):2987-3000. PubMed ID: 15051422 [TBL] [Abstract][Full Text] [Related]
10. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750 [TBL] [Abstract][Full Text] [Related]
11. H2O2 and Src-dependent transactivation of the EGF receptor mediates the stimulatory effect of leptin on renal ERK and Na+, K+-ATPase. Bełtowski J; Wójcicka G; Trzeciak J; Marciniak A Peptides; 2006 Dec; 27(12):3234-44. PubMed ID: 16973240 [TBL] [Abstract][Full Text] [Related]
12. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling. Banday AA; Lokhandwala MF Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of renal Na+, K+-ATPase: the possible novel mechanism of leptin-induced hypertension. Bełtowski J; Jamroz-Wiśniewska A; Borkowska E; Wójcicka G Pol J Pharmacol; 2004; 56(2):213-22. PubMed ID: 15156072 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Vaziri ND; Dicus M; Ho ND; Boroujerdi-Rad L; Sindhu RK Kidney Int; 2003 Jan; 63(1):179-85. PubMed ID: 12472781 [TBL] [Abstract][Full Text] [Related]
16. Chronic hyperleptinemia induces resistance to acute natriuretic and NO-mimetic effects of leptin. Bełtowski J; Wójcicka G; Jamroz-Wiśniewska A; Wojtak A Peptides; 2010 Jan; 31(1):155-63. PubMed ID: 19854228 [TBL] [Abstract][Full Text] [Related]
17. L-arginine or tempol supplementation improves renal and cardiovascular function in rats with reduced renal mass and chronic high salt intake. Carlström M; Brown RD; Yang T; Hezel M; Larsson E; Scheffer PG; Teerlink T; Lundberg JO; Persson AE Acta Physiol (Oxf); 2013 Apr; 207(4):732-41. PubMed ID: 23387940 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of natriuretic factors increases blood pressure in rats. Banday AA; Lokhandwala MF Am J Physiol Renal Physiol; 2009 Aug; 297(2):F397-402. PubMed ID: 19474184 [TBL] [Abstract][Full Text] [Related]
19. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats. Moreno JM; Rodríguez Gómez I; Wangensteen R; Osuna A; Bueno P; Vargas F Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E776-83. PubMed ID: 15941780 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling pathway to modulate central control of blood pressure. Cheng WH; Lu PJ; Ho WY; Tung CS; Cheng PW; Hsiao M; Tseng CJ Circ Res; 2010 Mar; 106(4):788-95. PubMed ID: 20056918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]